Selective phosphodiesterase 9A inhibitors as medicaments for improving cognitive processes

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9067945
APP PUB NO 20130245045A1
SERIAL NO

13886850

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to the use of selective phosphodiesterase 9A (PDE9A) inhibitors for producing medicaments for improving perception, concentration, cognitive processes, learning and/or memory.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BOEHRINGER INGEHLEIM INTERNATIONAL GMBHINGELHEIM AM RHEIN

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Böss, Frank-Gerhard Wuppertal, DE 8 41
Erb, Christina Kriftel, DE 40 830
Hendrix, Martin Odenthal, DE 50 1040
Van, Kampen Marja Neu-Isenburg, DE 33 660
Wunder, Frank Wuppertal, DE 137 2089

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 30, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00